😺 Mayo's AI spotted cancer 3 years before doctors did

😺 Mayo's AI spotted cancer 3 years before doctors did

Written By
Grant Harvey
Grant Harvey
May 5, 2026
9 minute read

Greg Brockman took the stand at the Musk v. Altman trial yesterday and confirmed his personal OpenAI stake is now worth nearly ~$30 billion. Not too shabby… But the star witness was not Brockman himself, but his journal

That’s right: Musk's lawyer read Brockman's personal journal aloud to the jury, including a 2017 entry asking himself "Financially, what will take me to $1B?" and another where Brockman described OpenAI's public commitment to its nonprofit mission as "a lie." 

Brockman's defense from the stand: these are hundreds of pages of stream-of-consciousness self-doubt, not some master plan. And just think, this was 2017, so before ChatGPT was good enough to actually conspire brainstorm with… wonder if these days Brockman does his scheming stream of consciousness self doubt journaling with GPT. 

Meanwhile, John Gruber of Daring Fireball did some investigative journalism and discovered that Y Combinator quietly owns roughly 0.6% of OpenAI (worth ~$5B at the current $852B valuation), which could mean YC co-founders Paul Graham and partner Jessica Livingston have personal billions riding on Sam Altman keeping his job. 

Gruber says Graham spent the last few weeks publicly defending Altman in that new “can we trust Sam Altman?” New Yorker piece and on X; and per Gruber, he's conspicuously stopped short of ever actually calling Altman trustworthy or a man of integrity. 

If only we had an impartial, totally unbiased, perhaps literally mechanical witness with absolutely nothing to gain to attest to Sam’s character once and for all… Wait, we’ve got it!

Picture Law and Order’s Jack McCoy: “Your Honor, the prosecution would like to call ChatGPT to the stand.” Who better to read someone’s chat logs into the record than the chatbot itself? Better hope you fixed those hallucinations fam!

Here’s what happened in AI today:

  • 😺 Mayo + Harvard: AI just beat doctors at their hardest jobs.

  • 📰 The White House quietly considers pre-release AI model vetting.

  • 📰 Anthropic and OpenAI both signed PE joint ventures.

  • 🍪 Cursor Team Kit ships the workflows Cursor devs use internally.

  • 🎓 Use o1 / Claude as a "second opinion" before big decisions.

Hey: Want to reach 700,000+ AI-hungry readers? Advertise with us! 

P.S: Love robots? We’re starting a new robotics newsletter! Sign up early here.

Two peer-reviewed studies dropped this week showing AI now beats specialist physicians at the two hardest parts of medicine: catching invisible disease early, and triaging patients in the first uncertain minutes.

First up: Mayo Clinic's REDMOD model spotted pancreatic cancer up to three years before diagnosis (study).

  • The team analyzed nearly 2,000 routine CT scans originally read as normal, including scans from patients later diagnosed with the disease. 

  • REDMOD flagged 73% of those prediagnostic cancers, vs. 39% caught by specialist radiologists looking at the same images. 

  • Median lead time: 16 months. 

  • For scans taken more than two years pre-diagnosis, the AI was three times more sensitive than human experts. 

This is a big deal. Pancreatic cancer kills most patients precisely because we catch it too late (13% five-year survival, 80% diagnosed at advanced stage). REDMOD changes that math.

Next up: Harvard's Science paper on OpenAI's o1, and admittedly older model, is fascinating. Researchers at Harvard, Beth Israel Deaconess, and Stanford ran six experiments pitting o1 against attending physicians (study).

  • The headline test: 76 real Beth Israel ER cases where the model got 67% of triage diagnoses exactly or near-exactly right. 

  • The two attendings scored 55% and 50%. 

  • Blinded reviewers couldn't tell which diagnoses came from the humans. 

  • The gap was largest in the first minutes of triage, when information is sparse and stakes are highest.

Now, it’s worth noting: Both teams stopped short of recommending clinical deployment and called for prospective trials.

Why this matters: These studies test something harder than memorized medical knowledge (Vox notes that "knowing the diagnosis isn't treating the patient"). They measure reasoning under uncertainty with incomplete information, which is, y’know, the actual hard part of medicine. AI cleared that bar twice in one week, on different problems. And this is far from frontier AI we’re talking about here, at least as far as the triaging study goes. 

Our take: AI-assisted triage in under-resourced ERs just became a near-term policy question. "Second opinion" tools may become standard before major diagnoses (the way spell-check became standard before sending an email… at least for SOME of us).

Now, Medical AI liability frameworks are nowhere near ready; but that's tomorrow's problem. Mayo's senior author Dr. Ajit Goenka put it cleanly: "In a disease where we have been just wandering in darkness for decades, this is a milestone that shows us the finish line, but we still have to get to the finish line." I think we all want a little bit more news like this, right? 

More than 50 companies are backing Arm’s move into silicon — spanning cloud, chip design and software.

From AWS, Google and Microsoft to NVIDIA, Samsung, SK hynix and TSMC, the ecosystem signals a broader shift in how AI infrastructure is being built.

Rather than isolated components, the stack is becoming more tightly integrated — from architecture through to deployment.

Today's Harvard study showed o1 (an older generation reasoning model from OpenAI) beating ER attendings most decisively in the first minutes of triage, when information is sparse and pressure is high.

Most workplace decisions look exactly like that: contract negotiations, hiring calls, architectural choices, budget approvals. The skill is feeding a reasoning model your conclusion plus your reasoning, then asking it to find what you missed.

I've concluded [DECISION] based on the following reasoning: [YOUR REASONING].
Before I commit, I want a structured second opinion. Please:
1. Identify the strongest argument against my conclusion.
2. Generate three alternative hypotheses I may have missed.
3. List the specific evidence or scenarios that would shift your assessment in either direction.
4. Flag any assumptions in my reasoning that look load-bearing but aren't actually supported.
Be direct. I'm looking for the version of this analysis I'd get from a sharp colleague who isn't trying to spare my feelings.

The trick is forcing yourself to write out your reasoning before pasting. Half the value is in that step alone; the model just stress-tests the rest.

Total AI beginner? Start here (goes with this video).

Have a specific skill you want to learn? Request it here. 

📰 Around the Horn

One brand built 30+ landing pages through Viktor without a single developer.

Each page mapped to a specific ad group. All deployed within hours. Viktor wrote the code and shipped every one from a Slack message.

That same team has Viktor monitoring ad accounts across the portfolio and posting performance briefs before the day starts. One colleague. Always on. Across every account.

5,700+ teams. 3,000+ integrations.

🐦 Tuesday Tweets:

Three from the weekend that earned their virality:

  • Justin Skycak (13,645 likes): "Never underestimate how much time and effort you can waste by trying to automate a process you do not understand manually." Tape this above your IDE.

  • Sam Altman (13,054 likes): "i keep thinking i want the models to be cheaper/faster more than i want them to be smarter but it seems that just being smarter is still the most important thing." The whole AI industry's quarterly roadmap, right there.

  • Mark Cuban (3,205 likes) on enterprise AI's biggest blocker: same question, different answers, every time. He frames the non-determinism as evidence against doomers since it proves the models clearly don't understand consequences.

A Cat’s Commentary

That’s all for now.

What'd you think of today's email?

Grant Harvey

Grant Harvey is the Lead Writer of The Neuron, where he continues to lead the publication's daily coverage of AI news, tools, and trends.

The Neuron Logo

Don't fall behind on AI. Get the AI trends & tools you need to know. Join 700,000+ professionals from top companies like Microsoft, Apple, Salesforce and more.

Property of TechnologyAdvice. © 2026 TechnologyAdvice. All Rights Reserved

Advertiser Disclosure: Some of the products that appear on this site are from companies from which TechnologyAdvice receives compensation. This compensation may impact how and where products appear on this site including, for example, the order in which they appear. TechnologyAdvice does not include all companies or all types of products available in the marketplace.